ThursdayMay 02, 2024 9:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Announces Fast-Anneal Feature Availability in Leap(TM) Quantum Cloud Service

Fast anneal is expected to impact various quantum computing applications, from advanced scientific research in quantum simulation to AI and solving real-world problems across wide spectrum of industries It expands upon D-Wave's groundbreaking optimization achievements, utilizing the comprehensive coherent annealing quantum computing provided by D-Wave's Advantage(TM) systems and the cutting-edge Advantage2(TM) prototype The introduction of the fast-anneal feature is poised to attract both commercial and academic researchers aiming to develop top-tier applications, broaden benchmarking investigations, and correlate heightened coherence with enhanced performance D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the world's first commercial…

Continue Reading

WednesdayMay 01, 2024 9:45 am

PaxMedica Inc. (NASDAQ: PXMD) Announces PAX-101 Batch Completion for NDA Application to FDA

PaxMedica has completed its three registration/validation batches of PAX-101, an IV formulation of suramin The completed batches are a significant step toward submitting a New Drug Application to the U.S. Food and Drug Administration in the fourth quarter of 2024 PaxMedica aims to establish a sustainable global supply chain for PAX-101 and to advance research and clinical trials targeting Autism Spectrum Disorder (“ASD”), demonstrating a steadfast commitment to addressing complex neurological conditions The ASD treatment market size was valued at $6.94 billion in 2022 and is projected to grow to $13.14 billion by 2030 PaxMedica (NASDAQ: PXMD), a biopharmaceutical company…

Continue Reading

WednesdayMay 01, 2024 9:00 am

Clene Inc. (NASDAQ: CLNN) Presents Findings on Phase 2 VISIONARY-MS LTE at American Academy of Neurology Annual Meeting

Long-term extension of the Phase 2 VISIONARY-MS clinical trial of CNM-Au8 exhibited significant evidence of repair and remyelination across multiple paraclinical endpoints (change from original baseline, p < 0.05) Significantly enhanced clinical outcomes were associated with long-term daily oral CNM-Au8(R) 30 mg treatment (change from original baseline; p < 0.05) Long-term administration of CNM-Au8, spanning up to three years, was well-tolerated, with no significant safety concerns identified This marks the first Phase 2 clinical trial in MS utilizing a non-immunomodulatory drug to achieve a clinical outcome demonstrating improved function supporting remyelination and reparative effects Clene (NASDAQ: CLNN), along with its…

Continue Reading

TuesdayApr 30, 2024 10:30 am

Freight Technologies Inc. (NASDAQ: FRGT) Reports 30% YOY Revenue Growth for Q1 2024; Projects $25-$30m Annual Revenue for 2024

Fr8Tech, a tech company on a mission to revolutionize cross-border shipping, just posted 30% year-over-year (“YOY”) revenue growth and a 278% YOY growth in Fr8Fleet volume for Q1 2024 This growth was attributed to the addition of the Fr8Fleet offering in 2022, which sought to address specific customer needs The company looks to build on this success by fostering even stronger relationships with existing customers and adding new customers to its network Its management believes that this approach will be integral in realizing its $25-$30 million annual revenue projection for the 2024 financial year Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a…

Continue Reading

TuesdayApr 30, 2024 9:45 am

SUIC Worldwide Holdings Ltd.’s (SUIC) I.Hart Group Expands Franchise Development Efforts with New Authorizations in China and Japan

SUIC recently announced that I.Hart Group Taiwan and MONGA(C) Fried Chicken had signed franchise authorizations in Japan and China The franchise authorizations are expected to grow the number of stores operated by I.Hart Group to 200 outlets in 2024 and more than 500 stores over the next five years The authorizations covering Shandong Province in China will see the Shandong Authorized company opening ten stores during the first year and 300 stores within the subsequent five years. Japan is another authorization which will target the greater Tokyo metropolitan area The new authorizations are part of SUIC’s commitment to grow its…

Continue Reading

TuesdayApr 30, 2024 9:00 am

Distributed Energy Solutions Provider Correlate Energy Corp. (CIPI) Uses Quality Toolkit and Financing Incentives to Help Clients Go Affordably Green

Industrial and commercial buildings are responsible for a significant amount of the carbon emissions affecting the planet’s climate, according to pollution experts Correlate Energy Corp. is a distributed energy solutions company, focusing on the North American market, that is dedicated to helping client companies improve their energy use profiles, reducing emissions while maintaining their budgets Correlate is strategically positioned to leverage government financial incentives on its clients’ behalf, as well as offering an array of modern, targeted tools to achieve data-driven solutions The company currently has about $150 million of in-progress projects in various stages of development The drive to…

Continue Reading

MondayApr 29, 2024 11:15 am

Astiva Health Inc. Innovative Holistic Approach Underscores Understanding That Effective Primary Care Is Foundational

PCPs play pivotal role in successful healthcare approach Evidence shows that primary care helps prevent illness and death Astiva Health has established a healthcare ecosystem where best PCPs are rewarded for expertise, commitment The importance of primary care in a successful healthcare approach has been clearly shown through decades of research. Astiva Health is dedicated to enhancing the quality of medical care through a strong doctor-patient relationship with the success of its model hinging on knowledgeable, competent, and hard-working primary care physicians (“PCPs”) who play a pivotal role in the healthcare system. “Evidence of the health-promoting influence of primary care…

Continue Reading

MondayApr 29, 2024 10:30 am

BioLargo, Inc. (BLGO) Leads in Cleantech Innovation with AEC Technology

BioLargo (OTCQB: BLGO), a pioneering cleantech and life sciences company, has made significant strides with its Aqueous Electrostatic Concentrator (“AEC”) technology, setting a new benchmark in the water treatment industry. This innovative technology has proven to effectively remove per- and polyfluoroalkyl substances (“PFAS”) from water, surpassing the stringent new U.S. Environmental Protection Agency (“EPA”) drinking water standards for PFAS chemicals set to take effect on April 10, 2024. The AEC technology's ability to generate significantly less PFAS-laden solid waste compared to traditional methods like carbon filtration or ion exchange positions it as a potentially more sustainable and cost-effective solution for…

Continue Reading

MondayApr 29, 2024 9:45 am

SOBRsafe Inc. (NASDAQ: SOBR) CEO Shares Focus for 2024 and Successes Marking Beginning of “Broad Adoption” in Behavioral Health and Justice Segments

SOBRsafe CEO Dave Gandini recently communicated the company’s 2023 progress in expanding its line of products as well as its sales outreach and focus for 2024; view the video here Last fall, SOBRsafe’s management directed the company’s sales effort toward the behavioral health and justice segments, sectors that already have embedded alcohol monitoring procedures, but need better monitoring and screening solutions SOBRsafe provides SOBRsure(TM) and SOBRcheck(TM), next-generation touch-based alcohol detection and monitoring solutions that fit the behavioral health and justice segments “to a tee,” according to Gandini As a result of its redirected efforts, the company has secured 16 new…

Continue Reading

MondayApr 29, 2024 9:00 am

HealthLynked Corp. (HLYK) Is ‘One to Watch’

HealthLynked Corp. is a pioneering healthcare technology company revolutionizing patient care through innovative digital solutions Dr. Michael T. Dent, CEO and Chairman, leads the company with a significant history of successful healthcare management and technology development; his prior leadership at NeoGenomics Laboratories, a company with a current market cap of approximately $2 billion, underscores his ability to scale healthcare solutions in competitive markets HealthLynked’s recently launched HealthLynked Network is a state-of-the-art, cloud-based platform designed to significantly improve the efficiency and quality of patient care by enabling a seamless exchange of medical information The leadership’s deep involvement and commitment are reflected…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered